55 related articles for article (PubMed ID: 23157172)
1. Salt chamber treatment is ineffective in treating eosinophilic inflammation in asthma.
Sandell J; Hedman J; Saarinen K; Haahtela T
Allergy; 2013 Jan; 68(1):125-7. PubMed ID: 23157172
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial on the effect of montelukast on sputum eosinophil cationic protein in children with corticosteroid-dependent asthma.
Strauch E; Moske O; Thoma S; Storm Van's Gravesande K; Ihorst G; Brandis M; Kuehr J
Pediatr Res; 2003 Aug; 54(2):198-203. PubMed ID: 12736396
[TBL] [Abstract][Full Text] [Related]
3. Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma.
Hothersall EJ; Chaudhuri R; McSharry C; Donnelly I; Lafferty J; McMahon AD; Weir CJ; Meiklejohn J; Sattar N; McInnes I; Wood S; Thomson NC
Thorax; 2008 Dec; 63(12):1070-5. PubMed ID: 18757458
[TBL] [Abstract][Full Text] [Related]
4. Sputum indoleamine-2, 3-dioxygenase activity is increased in asthmatic airways by using inhaled corticosteroids.
Maneechotesuwan K; Supawita S; Kasetsinsombat K; Wongkajornsilp A; Barnes PJ
J Allergy Clin Immunol; 2008 Jan; 121(1):43-50. PubMed ID: 18036645
[TBL] [Abstract][Full Text] [Related]
5. Fevipiprant, a prostaglandin D2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial.
Gonem S; Berair R; Singapuri A; Hartley R; Laurencin MFM; Bacher G; Holzhauer B; Bourne M; Mistry V; Pavord ID; Mansur AH; Wardlaw AJ; Siddiqui SH; Kay RA; Brightling CE
Lancet Respir Med; 2016 Sep; 4(9):699-707. PubMed ID: 27503237
[TBL] [Abstract][Full Text] [Related]
6. Cromolyn sodium suppresses eosinophilic inflammation in patients with aspirin-intolerant asthma.
Amayasu H; Nakabayashi M; Akahori K; Ishizaki Y; Shoji T; Nakagawa H; Hasegawa H; Yoshida S
Ann Allergy Asthma Immunol; 2001 Aug; 87(2):146-50. PubMed ID: 11527248
[TBL] [Abstract][Full Text] [Related]
7. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
[TBL] [Abstract][Full Text] [Related]
8. Effects of different anti-asthmatic agents on induced sputum and eosinophil cationic protein in mild asthmatics.
Basyigit I; Yildiz F; Kacar Ozkara S; Boyaci H; Ilgazli A; Ozkarakas O
Respirology; 2004 Nov; 9(4):514-20. PubMed ID: 15612964
[TBL] [Abstract][Full Text] [Related]
9. [The relationship between sputum eosinophils and responses to treatment of inhaled glucocorticoids in patients with persistent asthma].
Jiang YW; Sun YC; Zhou QT; Gai XY; Cao WL; Yao WZ
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):447-51. PubMed ID: 17673020
[TBL] [Abstract][Full Text] [Related]
10. Safety and application of induced sputum analysis in childhood asthma.
Covar RA; Spahn JD; Martin RJ; Silkoff PE; Sundstrom DA; Murphy J; Szefler SJ
J Allergy Clin Immunol; 2004 Sep; 114(3):575-82. PubMed ID: 15356559
[TBL] [Abstract][Full Text] [Related]
11. [The small airway inflammation of asthmatic patients who have used dry powder type inhaled steroid for moderate-long term evaluated by induced sputum and the efficacy of HFA-BDP (QVAR) inhalation].
Ohbayashi H
Arerugi; 2005 Jan; 54(1):24-35. PubMed ID: 15841673
[TBL] [Abstract][Full Text] [Related]
12. Responsiveness to oral prednisolone in severe asthma is related to the degree of eosinophilic airway inflammation.
Sousa AR; Marshall RP; Warnock LC; Bolton S; Hastie A; Symon F; Hargadon B; Marshall H; Richardson M; Brightling CE; Haldar P; Milone R; Chalk P; Williamson R; Panettieri R; Knowles R; Bleecker ER; Wardlaw AJ
Clin Exp Allergy; 2017 Jul; 47(7):890-899. PubMed ID: 28493293
[TBL] [Abstract][Full Text] [Related]
13. The effect of salt chamber treatment on bronchial hyperresponsiveness in asthmatics.
Hedman J; Hugg T; Sandell J; Haahtela T
Allergy; 2006 May; 61(5):605-10. PubMed ID: 16629791
[TBL] [Abstract][Full Text] [Related]
14. Association between neutrophilic and eosinophilic inflammation in patients with severe persistent asthma.
Kikuchi S; Nagata M; Kikuchi I; Hagiwara K; Kanazawa M
Int Arch Allergy Immunol; 2005; 137 Suppl 1():7-11. PubMed ID: 15947478
[TBL] [Abstract][Full Text] [Related]
15. "Refractory" eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids.
ten Brinke A; Zwinderman AH; Sterk PJ; Rabe KF; Bel EH
Am J Respir Crit Care Med; 2004 Sep; 170(6):601-5. PubMed ID: 15215154
[TBL] [Abstract][Full Text] [Related]
16. Obesity in asthma: more neutrophilic inflammation as a possible explanation for a reduced treatment response.
Telenga ED; Tideman SW; Kerstjens HA; Hacken NH; Timens W; Postma DS; van den Berge M
Allergy; 2012 Aug; 67(8):1060-8. PubMed ID: 22686834
[TBL] [Abstract][Full Text] [Related]
17. Step-down of inhaled corticosteroids in non-eosinophilic asthma: A prospective trial in real life.
Demarche S; Schleich F; Henket M; Paulus V; Louis R; Van Hees T
Clin Exp Allergy; 2018 May; 48(5):525-535. PubMed ID: 29383782
[TBL] [Abstract][Full Text] [Related]
18. Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids.
Deykin A; Lazarus SC; Fahy JV; Wechsler ME; Boushey HA; Chinchilli VM; Craig TJ; Dimango E; Kraft M; Leone F; Lemanske RF; Martin RJ; Pesola GR; Peters SP; Sorkness CA; Szefler SJ; Israel E;
J Allergy Clin Immunol; 2005 Apr; 115(4):720-7. PubMed ID: 15805990
[TBL] [Abstract][Full Text] [Related]
19. Bromotyrosines in sputum proteins and treatment effects of terbutaline and budesonide in asthma.
van Dalen CJ; Aldridge RE; Chan T; Senthilmohan R; Hancox RJ; Cowan JO; Taylor DR; Town GI; Kettle AJ
Ann Allergy Asthma Immunol; 2009 Oct; 103(4):348-53. PubMed ID: 19852201
[TBL] [Abstract][Full Text] [Related]
20. Effects of montelukast compared to double dose budesonide on airway inflammation and asthma control.
Barnes N; Laviolette M; Allen D; Flood-Page P; Hargreave F; Corris P; O'Connor B; Tate H; Parker D; Pavord I
Respir Med; 2007 Aug; 101(8):1652-8. PubMed ID: 17481879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
